Upgrade to SI Premium - Free Trial

Amgen (AMGN) Receives CRL from FDA on Parsabiv NDA

August 24, 2016 6:06 PM
Amgen (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles